Clinical Trial Update: Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and tolerability of intravitreal VEGF-Trap (aflibercept) in patients with neovascular age-related macular degeneration. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• VEGF Trap-Eye (aflibercept)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Macular Degeneration | Phase 1 | Status: COMPLETED